Dr. Mark A. Hoffman, an attorney with Ross Feller Casey, was appointed this week to serve on the Plaintiffs Steering Committee in litigation involving the blood thinning drug Xarelto.
Hoffman was appointed to the leadership role by Judge Eldon E. Fallon of the U.S. District Court for the Eastern District of Louisiana.
Xarelto is a popular anticoagulant drug that has been linked to severe internal bleeding, gastrointestinal hemorrhaging, strokes and other serious side effects.
Ross Feller Casey is actively pursuing numerous cases against the makers of Xarelto, Johnson & Johnson's Janssen Pharmaceuticals and Bayer.
Hoffman also is serving on the Plaintiffs Steering Committees in cases involving Testosterone replacement therapy drugs currently being litigated before the U.S. District Court for the Northern District of Illinois
Additionally, Ross Feller Casey's Brian J. McCormick, Jr., is serving on the Plaintiffs Steering Committee in the Risperdal and Invega product liability cases before the Superior Court of California.
Ross Feller Casey is one of only two firms in the entire nation with attorneys serving on the steering committees for the three top mass tort litigations.
As members of the committees, Hoffman and McCormick will play integral roles in shaping plaintiff's cases as those mass tort cases progress.